Related references
Note: Only part of the references are listed.Involvement of Infralimbic Prefrontal Cortex but not Lateral Habenula in Dopamine Attenuation After Chronic Mild Stress
Jared L. Moreines et al.
NEUROPSYCHOPHARMACOLOGY (2017)
PPAR-γ Agonists for the Treatment of Major Depression: A Review
R. Colle et al.
PHARMACOPSYCHIATRY (2017)
The exercise-glucocorticoid paradox: How exercise is beneficial to cognition, mood, and the brain while increasing glucocorticoid levels
Chong Chen et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2017)
Pioglitazone attenuates lipopolysaccharide-induced depression-like behaviors, modulates NF-κB/IL-6/STAT3, CREB/BDNF pathways and central serotonergic neurotransmission in mice
L. Liao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Pioglitazone could induce remission in major depression: a meta-analysis
Romain Colle et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al.
AUTOPHAGY (2016)
Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment
Silvia Alboni et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice
Jing Wen et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Depression mediates impaired glucose tolerance and cognitive dysfunction: A neuromodulatory role of rosiglitazone
Sita Sharan Patel et al.
HORMONES AND BEHAVIOR (2016)
Icariin attenuates cerebral ischemia-reperfusion injury through inhibition of inflammatory response mediated by NF-kappa B, PPAR alpha and PPAR gamma in rats
Deqing Xiong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression
Xiaolie He et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Clearing Amyloid-beta through PPAR gamma/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease
Vicent Bonet-Costa et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Involvement of PI3K/Akt/FoxO3a and PKA/CREB Signaling Pathways in the Protective Effect of Fluoxetine Against Corticosterone-Induced Cytotoxicity in PC12 Cells
Bingqing Zeng et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation
Milena Pinto et al.
MOLECULAR NEURODEGENERATION (2016)
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
M-L Wong et al.
MOLECULAR PSYCHIATRY (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
Fluoxetine protects against IL-1β-induced neuronal apoptosis via downregulation of p53
Han Shan et al.
NEUROPHARMACOLOGY (2016)
Antidepressant therapies inhibit inflammation and microglial M1-polarization
Hans O. Kalkman et al.
PHARMACOLOGY & THERAPEUTICS (2016)
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
Rebecca J. Henry et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Impaired GABA synthesis, uptake and release are associated with depression-like behaviors induced by chronic mild stress
K. Ma et al.
TRANSLATIONAL PSYCHIATRY (2016)
Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma
Alexandre Vallee et al.
FRONTIERS IN NEUROSCIENCE (2016)
The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain
Eduardo Maria Normando et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection
Erwan Thouennon et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: New evidence on neuroprotection in a rat model of global cerebral ischemia
Zi-Qiang Shao et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
HIPPOCAMPAL NEUROPLASTICITY IN MAJOR DEPRESSIVE DISORDER
N. V. Malykhin et al.
NEUROSCIENCE (2015)
Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke
Michelangelo Certo et al.
PHARMACOLOGICAL RESEARCH (2015)
Molecular network of neuronal autophagy in the pathophysiology and treatment of depression
Jack Jia et al.
NEUROSCIENCE BULLETIN (2015)
Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus
Kai G. Kahl et al.
BRAIN AND BEHAVIOR (2015)
Cobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin
Elke Biemans et al.
ACTA DIABETOLOGICA (2015)
Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone
Y. Cheng et al.
MOLECULAR PSYCHIATRY (2015)
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack
Jia Liu et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Autophagy and Its Normal and Pathogenic States in the Brain
Ai Yamamoto et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 37 (2014)
Lack of seipin in neurons results in anxiety- and depression-like behaviors via down regulation of PPARγ
Libin Zhou et al.
HUMAN MOLECULAR GENETICS (2014)
Impaired autophagy: a link between neurodegenerative and neuropsychiatric diseases
Mira Polajnar et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
The role of mTOR in depression and antidepressant responses
Helena M. Abelaira et al.
LIFE SCIENCES (2014)
Hippocampal HDAC4 Contributes to Postnatal Fluoxetine-Evoked Depression-Like Behavior
Ambalika Sarkar et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans
Nils C. Gassen et al.
PLOS MEDICINE (2014)
Neuroinflammation and Comorbidity of Pain and Depression
A. K. Walker et al.
PHARMACOLOGICAL REVIEWS (2014)
Prolonged Restraint Stress Increases IL-6, Reduces IL-10, and Causes Persistent Depressive-Like Behavior That Is Reversed by Recombinant IL-10
Jeffrey L. Voorhees et al.
PLOS ONE (2013)
Hormones and the Social Brain
Bruce S. McEwen
SCIENCE (2013)
Adolescent Stress-Induced Epigenetic Control of Dopaminergic Neurons via Glucocorticoids
Minae Niwa et al.
SCIENCE (2013)
Chronic Stress Triggers Social Aversion via Glucocorticoid Receptor in Dopaminoceptive Neurons
Jacques Barik et al.
SCIENCE (2013)
Adult hippocampal neurogenesis buffers stress responses and depressive behaviour
Jason S. Snyder et al.
NATURE (2011)
Vital exhaustion, depressive symptoms and serum triglyceride levels in high-risk middle-aged men
Cornel Victor Igna et al.
PSYCHIATRY RESEARCH (2011)
Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling
Jinguo Yan et al.
AUTOPHAGY (2010)
Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis
A. Nouwen et al.
DIABETOLOGIA (2010)
Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study
Natalie L. Rasgon et al.
THESCIENTIFICWORLDJOURNAL (2010)
Examining a bidirectional association between depressive symptoms and diabetes
Sherita Hill Golden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The molecular neurobiology of depression
Vaishnav Krishnan et al.
NATURE (2008)
Diabetes, depression, and quality of life - A population study
RD Goldney et al.
DIABETES CARE (2004)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R).
RC Kessler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine
B Czéh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
